Advertisement
Screener

ENDRA LIFE SCIENCES INC. (NDRA) Form D

ENDRA LIFE SCIENCES INC. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2019-07-31: Federal exemption Rule 506(b); Types of securities offered Debt; OptionToAcquire; SecurityToBeAcquired; Convertible promissory notes and shares of common stock issuable upon conversion. Warrants and shares of common stock issuable upon exercise.; Date of first sale 2019-07-26; Total offering amount $2,805,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2019-07-31Rule 506(b)Debt; OptionToAcquire; SecurityToBeAcquired; Convertible promissory notes and shares of common stock issuable upon conversion. Warrants and shares of common stock issuable upon exercise.2019-07-26$2,805,000$2,805,000$086

Similar stocks

Stock NameCountryMarket CapPE Ratio
IRIDEX CORP (IRIX)United States$0.011B
Nuwellis, Inc. (NUWE)United States$0.003B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
Outset Medical, Inc. (OM)United States$0.059B-1.09
Streamex Corp. (STEX)United States$0.089B-0.19
Nexalin Technology, Inc. (NXL)United States$0.094B
Neuraxis, INC (NRXS)United States$0.097B
electroCore, Inc. (ECOR)United States$0.102B
Vivani Medical, Inc. (VANI)United States$0.111B